Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 16, 2019
Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate CancerO Naismith, H Mayles, M Bidmead, et al.
British Journal of Cancer|April 22, 2015
Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladderS Hafeez, A Horwich, O Omar, et al.
Prostate Cancer and Prostatic Diseases|March 29, 2003
Germline mutations in fumarate hydratase (FH) do not predispose to prostate cancerS Bevan, S M Edwards, A Ardern Jones, et al.
Oncology|May 1, 1993
Role of ondansetron plus dexamethasone in fractionated chemotherapyU Räth, B K Upadhyaya, E Arechavala, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2010
The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancerGary J R Cook, Ram Venkitaraman, Aslam S Sohaib, et al.
Clinical Radiology|January 4, 2015
Progressive computed tomography (CT) appearances preceding malignant spinal cord compression (MSCC) in men with castration-resistant prostate cancerC Pezaro, A Omlin, R Perez-Lopez, et al.
The British Journal of Radiology|May 20, 2008
Correlation of diffusion-weighted MRI with whole mount radical prostatectomy specimensN Van As, E Charles-Edwards, A Jackson, et al.
Prostate Cancer and Prostatic Diseases|September 3, 2008
Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillanceS Jhavar, J Bartlett, G Kovacs, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 12, 2019
The Intensity-Modulated Pelvic Node and Bladder Radiotherapy (IMPART) Trial: A Phase II Single-Centre Prospective StudyM P Tan, V Harris, K Warren-Oseni, et al.
British Journal of Cancer|October 15, 2014
Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abirateroneD Lorente, A Omlin, R Ferraldeschi, et al.
Pageof 6